$BLUE
bluebird bio, Inc.

2015 Q2 Form 10-Q Financial Statement

#000156459016022374 Filed on August 03, 2016

View on sec.gov

Income Statement

Concept 2015 Q2
Revenue $4.940M
YoY Change -22.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.70M
YoY Change 87.72%
% of Gross Profit
Research & Development $44.27M
YoY Change 217.75%
% of Gross Profit
Depreciation & Amortization $1.800M
YoY Change 233.33%
% of Gross Profit
Operating Expenses $56.96M
YoY Change 189.61%
Operating Profit -$52.02M
YoY Change 290.15%
Interest Expense -$2.000M
YoY Change
% of Operating Profit
Other Income/Expense, Net $228.0K
YoY Change 1972.73%
Pretax Income -$51.80M
YoY Change 288.76%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$51.80M
YoY Change 3294.17%
Net Earnings / Revenue -1048.48%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.570M
COMMON SHARES
Basic Shares Outstanding 32.83M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $810.5M
YoY Change 361.3%
Cash & Equivalents $593.3M
Short-Term Investments $217.2M
Other Short-Term Assets $4.900M
YoY Change -31.94%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $815.5M
YoY Change 345.95%
LONG-TERM ASSETS
Property, Plant & Equipment $16.80M
YoY Change 30.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $125.9M
YoY Change
Other Assets $1.500M
YoY Change -11.76%
Total Long-Term Assets $183.7M
YoY Change 218.08%
TOTAL ASSETS
Total Short-Term Assets $815.5M
Total Long-Term Assets $183.7M
Total Assets $999.2M
YoY Change 315.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.300M
YoY Change -11.06%
Accrued Expenses $15.30M
YoY Change 30.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.00M
YoY Change -29.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $51.80M
YoY Change 14615.91%
Total Long-Term Liabilities $51.80M
YoY Change 14615.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.00M
Total Long-Term Liabilities $51.80M
Total Liabilities $80.20M
YoY Change 7.12%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $919.0M
YoY Change
Total Liabilities & Shareholders Equity $999.2M
YoY Change 315.26%

Cashflow Statement

Concept 2015 Q2
OPERATING ACTIVITIES
Net Income -$51.80M
YoY Change 3294.17%
Depreciation, Depletion And Amortization $1.800M
YoY Change 233.33%
Cash From Operating Activities -$12.12M
YoY Change 6.97%
INVESTING ACTIVITIES
Capital Expenditures -$1.410M
YoY Change -29.85%
Acquisitions
YoY Change
Other Investing Activities -$6.580M
YoY Change 40.9%
Cash From Investing Activities -$7.990M
YoY Change 19.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 480.2M
YoY Change 38943.9%
NET CHANGE
Cash From Operating Activities -12.12M
Cash From Investing Activities -7.990M
Cash From Financing Activities 480.2M
Net Change In Cash 460.1M
YoY Change -2840.5%
FREE CASH FLOW
Cash From Operating Activities -$12.12M
Capital Expenditures -$1.410M
Free Cash Flow -$10.71M
YoY Change 14.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10782000
CY2015Q4 us-gaap Liabilities
Liabilities
151841000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-226000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1649000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-113469000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
200000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
900000
blue Fair Value Of Contingent Consideration Non Cash
FairValueOfContingentConsiderationNonCash
1001000
blue Fair Value Of Contingent Consideration Non Cash
FairValueOfContingentConsiderationNonCash
2188000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4747000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3509000
us-gaap Share Based Compensation
ShareBasedCompensation
20926000
us-gaap Share Based Compensation
ShareBasedCompensation
21482000
us-gaap Other Noncash Expense
OtherNoncashExpense
1563000
us-gaap Other Noncash Expense
OtherNoncashExpense
269000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1722000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1059000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3132000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-418000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2497000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1098000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7669000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13716000
blue Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
469000
blue Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
-480000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-81100000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36277000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-209000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-359000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6057000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2568000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
80845000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
261440000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
226825000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
62680000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
140132000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-200969000
blue Payments Of Contingent Purchase Price Consideration
PaymentsOfContingentPurchasePriceConsideration
2025000
blue Proceeds From Public Offering Of Common Stock Net Of Issuance Costs
ProceedsFromPublicOfferingOfCommonStockNetOfIssuanceCosts
477179000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1353000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5521000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-672000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
482700000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
58360000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
245454000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
347845000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
593299000
blue Construction Financing Obligation Non Cash
ConstructionFinancingObligationNonCash
24725000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
909000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
524000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1992-04-16
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
81000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2313000
CY2016Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
556373000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
701494000
CY2016Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
779002000
CY2016Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
6082000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
2500000
CY2016Q2 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2015Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2016Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2914000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
118928000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
89435000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9629000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6821000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5780000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5935000
CY2016Q2 blue Accrued Goods And Services
AccruedGoodsAndServices
19210000
CY2015Q4 blue Accrued Goods And Services
AccruedGoodsAndServices
16153000
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1861000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1014000
CY2016Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1013000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
964000
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3584000
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1032000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
495000
CY2013Q2 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P9Y
CY2013Q2 blue Area Of Leased Space
AreaOfLeasedSpace
43600
CY2013Q2 blue Lease Amendment Effective Month And Year
LeaseAmendmentEffectiveMonthAndYear
2014-06
CY2013Q2 blue Additional Lease Space Agreement
AdditionalLeaseSpaceAgreement
9900
CY2013Q2 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
200000
CY2014Q4 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
300000
CY2013Q2 us-gaap Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
P5Y
CY2013Q2 blue Landlord Contribution For Leasehold Improvements
LandlordContributionForLeaseholdImprovements
7800000
CY2013Q2 blue Letter Of Credit Related To New Lease Agreement
LetterOfCreditRelatedToNewLeaseAgreement
1300000
CY2016Q2 blue Letter Of Credit Related To New Lease Agreement
LetterOfCreditRelatedToNewLeaseAgreement
600000
CY2016Q2 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-200000
CY2013Q2 blue Lease Starting Date
LeaseStartingDate
2013-06-03
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
1500000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1200000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16050000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20926000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21482000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3532000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
840000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
90000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
179000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1788000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4049000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
50.14
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.13
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
32.76
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
49.45
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1000000
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
500000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4451000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4331000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4103000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.97
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4451000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4331000

Files In Submission

Name View Source Status
0001564590-16-022374-index-headers.html Edgar Link pending
0001564590-16-022374-index.html Edgar Link pending
0001564590-16-022374.txt Edgar Link pending
0001564590-16-022374-xbrl.zip Edgar Link pending
blue-10q_20160630.htm Edgar Link pending
blue-20160630.xml Edgar Link completed
blue-20160630.xsd Edgar Link pending
blue-20160630_cal.xml Edgar Link unprocessable
blue-20160630_def.xml Edgar Link unprocessable
blue-20160630_lab.xml Edgar Link unprocessable
blue-20160630_pre.xml Edgar Link unprocessable
blue-ex1037_62.htm Edgar Link pending
blue-ex311_12.htm Edgar Link pending
blue-ex312_14.htm Edgar Link pending
blue-ex321_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending